Skip to main content

Diphtheria Toxoid / Haemophilus B Conjugate (Prp-Omp) Vaccine / Hepatitis B Pediatric Vaccine / Pertussis, Acellular / Poliovirus Vaccine, Inactivated / Tetanus Toxoid Dosage

Medically reviewed by Drugs.com. Last updated on Aug 21, 2023.

Usual Pediatric Dose for Haemophilus influenzae Prophylaxis

3 dose series: 0.5 mL intramuscularly at 2, 4, and 6 months of age

Comments:


Uses: Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Hemophilus influenzae type B

Usual Pediatric Dose for Poliomyelitis Prophylaxis

3 dose series: 0.5 mL intramuscularly at 2, 4, and 6 months of age

Comments:


Uses: Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Hemophilus influenzae type B

Usual Pediatric Dose for Diphtheria Prophylaxis

3 dose series: 0.5 mL intramuscularly at 2, 4, and 6 months of age

Comments:


Uses: Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Hemophilus influenzae type B

Usual Pediatric Dose for Pertussis Prophylaxis

3 dose series: 0.5 mL intramuscularly at 2, 4, and 6 months of age

Comments:


Uses: Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Hemophilus influenzae type B

Usual Pediatric Dose for Tetanus Prophylaxis

3 dose series: 0.5 mL intramuscularly at 2, 4, and 6 months of age

Comments:


Uses: Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Hemophilus influenzae type B

Usual Pediatric Dose for Hepatitis B Prophylaxis

3 dose series: 0.5 mL intramuscularly at 2, 4, and 6 months of age

Comments:


Uses: Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Hemophilus influenzae type B

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:


Safety and efficacy have not been established in patients younger than 6 weeks or older than 4 years (before 5th birthday).

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

Monitoring:
Respiratory: Apnea

Patient advice:

More about diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid

Patient resources

Other brands

Vaxelis

Professional resources

Other brands

Vaxelis

Related treatment guides

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.